In a landmark development for Indian life sciences and biotechnology, Hyderabad-based SCIINV Biosciences has developed India’s first AI-driven antimicrobial candidate using an advanced ...

From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...

Hyderabad-based SCIINV Biosciences has identified a new AI-driven repurposed antibiotic now entering human clinical trials. The breakthrough, backed by Whale Tank Biocatalyst, reduces development time ...

Chris Rosica, president and CEO of Rosica Communications, an award-winning nonprofit PR agency, was selected to give a dynamic, 60-minute talk at the Nonprofit Technology Conference (NTC) in Detroit, ...

Peptris plans on utilising the fresh capital to bolster its clinical readiness while also expanding its pipeline over the ...

Peptris will use the capital raised to advance its existing programmes toward clinical readiness and to expand its pipeline ...

Electric vehicle charging platform Statiq, semiconductor company Vervesemi, AI drug discovery firm Peptris, nutraceuticals brand Zeroharm ...

Description: Experts argue LLMs won’t be the end-state: new architectures (multimodal, agentic, beyond transformers) will supersede them.

Is the $600B AI Capex splurge repeating the 1999 fiber optic overbuild? Analyze the risks of an AI Bubble 2026, comparing the dot-com crash to today’s data center arms race.

IAN Alpha Fund, the 2nd in the series of IAN Group’s VC funds, along with Speciale Invest, has co-led a ₹70 crore Series A ...

Cambrex, a leading global contract development and manufacturing organization (CDMO) and Snapdragon Chemistry, a Cambrex company, are proud to announce that Dr. Song Lin, Tisch University Professor in ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.